Digital dichotomy
The challenge of achieving functioning NHS digital change cost-effectively - Magazine Article - PharmaTimes
https://www.pharmatimes.com/magazine/2023/april_2023/digital_dichotomyThe challenge of achieving functioning NHS digital change cost-effectively - Magazine Article - PharmaTimes
https://www.pharmatimes.com/magazine/2023/april_2023/digital_dichotomyHow we produce medicines must focus on materials, net-zero and our carbon footprint, but how we work also needs to change - News - PharmaTimes
by Josephine Dimbleby MCIWM is Business Development Manager at Axil Integrated Services
https://www.pharmatimes.com/thought_leadership/countdown_conundrum_1490307Companies are getting closer to their end users but does industry really understand its customers? - Magazine Article - PharmaTimes
https://www.pharmatimes.com/magazine/2023/april_2023/talking_the_talkIs breast cancer care across Europe good enough? - Magazine Article - PharmaTimes
https://www.pharmatimes.com/magazine/2023/april_2023/uncomfortable_truthsHCP common goals – a deal with the devil or a blessing in disguise? - Magazine Article - PharmaTimes
https://www.pharmatimes.com/magazine/2023/april_2023/moving_on_upObtaining the right mix of patients from different ethnic, racial and demographic backgrounds requires a strategic approach leveraging community-based resources and patient-friendly technologies - Magazine Article - PharmaTimes
https://www.pharmatimes.com/magazine/2023/april_2023/a_design_for_lifeNavigating the maze of NHS medicines optimisation requires a truly joined-up approach - Magazine Article - PharmaTimes
https://www.pharmatimes.com/magazine/2023/april_2023/optimise_this!In an ever-complex regulatory environment – and a rapidly evolving digital landscape –adopting an effective digital transformation strategy is pivotal - Magazine Article - PharmaTimes
https://www.pharmatimes.com/magazine/2023/april_2023/evolution_energisedResults from trial showed a long-term response among specific lung cancer population - News - PharmaTimes
by John Pinching
https://www.pharmatimes.com/news/janssens_rybrevant_yields_positive_data_1490345How can big pharma and SME pharma work to mutual advantage and help patients with unmet medical need?
https://www.pharmatimes.com/thought_leadership/hidden_gems_1279610